BioSpace News Archive

IVERIC bio, Inc. announced that Glenn P. Sblendorio, Chief Executive Officer and President of IVERIC bio, will present an overview of the Company at the Chardan Capital Markets 3rd Annual Genetic Medicines Conference in New York on Monday, October 7, 2019 at 8:30 a.m. Eastern Time.

YuJa Inc. formally announces a partnership with Philadelphia College of Osteopathic Medicine to provide a campus-wide lecture capture system and video management solution to both their Philadelphia and Suwanee campuses.

Vertex Pharmaceuticals Incorporated and RNA therapeutics developer Ribometrix, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel RNA-targeted small molecule therapeutic candidates for serious diseases.

Medable Inc., leading the transformation of clinical trials with a digital trials platform connecting patients, sites, and clinical trial teams, will demonstrate a number of integrated eClinical, telemedicine, and data management solutions at the 2019 Society of Clinical Data Management Annual Conference, booth #607, September 29 – October 2 in Baltimore, Maryland.

Preliminary evidence of tolerability and anti-tumor activity, and Maximum Tolerated Dose (MTD) established

Oncopeptides AB announces that the number of shares and votes in Oncopeptides has changed as a result of exercise of warrants under the company’s incentive programs.

Administration of onvansertib in combination with standard-of-care chemotherapy is safe and well-tolerated and resulted in anti-leukemic activity that appears to be sustainable over time

Moderna, Inc. announced the U.S. Food and Drug Administration has completed their review of the Investigational New Drug application for mRNA-3927, its investigational mRNA therapeutic for propionic acidemia and allowed it to proceed to clinic.

Company Offices in Rockville, Frederick and Tysons Corner Allow Employees to Choose a Location Closest to Home

Stoke Therapeutics, Inc. announced that Chief Executive Officer Edward M. Kaye, M.D., will present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2, 2019 at 10:05 a.m. Eastern time in New York, New York.